HSBC Holdings’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.2M | Buy |
98,118
+14,546
| +17% | +$1.52M | 0.01% | 769 |
|
|
2025
Q1 | $9.74M | Sell |
83,572
-53,213
| -39% | -$6.2M | 0.01% | 767 |
|
|
2024
Q4 | $11.6M | Sell |
136,785
-279
| -0.2% | -$23.6K | 0.01% | 758 |
|
|
2024
Q3 | $12.3M | Buy |
137,064
+133,279
| +3,521% | +$12M | 0.01% | 750 |
|
|
2024
Q2 | $301K | Sell |
3,785
-1,051
| -22% | -$83.5K | ﹤0.01% | 1927 |
|
|
2024
Q1 | $386K | Sell |
4,836
-75,601
| -94% | -$6.03M | ﹤0.01% | 1859 |
|
|
2023
Q4 | $6.37M | Sell |
80,437
-68,375
| -46% | -$5.41M | 0.01% | 880 |
|
|
2023
Q3 | $10.4M | Buy |
+148,812
| New | +$10.4M | 0.01% | 705 |
|
|
2021
Q1 | – | Sell |
-2,593
| Closed | -$211K | – | 2332 |
|
|
2020
Q4 | $211K | Buy |
+2,593
| New | +$211K | ﹤0.01% | 2347 |
|
|
2020
Q1 | – | Sell |
-2,401
| Closed | -$254K | – | 2242 |
|
|
2019
Q4 | $254K | Buy |
+2,401
| New | +$254K | ﹤0.01% | 2145 |
|